|
|
|
Insider
Information: |
Schinazi Raymond F |
Relationship: |
Director |
City: |
Atlanta |
State: |
GA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
7,674,960 |
|
Indirect Shares
|
1,088,641 |
|
|
Direct
Value |
$19,802,164 |
|
|
Indirect Value
|
$3,735,551 |
|
|
Total
Shares |
8,763,601 |
|
|
Total
Value |
$23,537,716 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-77.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cocrystal Pharma |
COCP |
10% Owner |
2021-05-04 |
7,674,960 |
2019-10-25 |
995,593 |
Premium* |
|
Precision Biosciences Inc |
DTIL |
Director |
2019-04-01 |
0 |
2019-04-01 |
93,048 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
COCP |
Cocrystal Pharma |
|
|
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
269,114,822 |
269,114,822 |
0 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-04-21 |
4 |
B |
$0.92 |
$3,187,667 |
D/D |
3,464,855 |
272,579,677 |
3.92 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-03-15 |
4 |
B |
$0.51 |
$1,500,000 |
D/D |
2,941,176 |
275,520,853 |
3.92 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-09-01 |
4 |
B |
$0.41 |
$2,000,000 |
I/I |
4,878,050 |
4,878,050 |
2.25 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2017-04-20 |
4 |
A |
$0.24 |
$1,000,000 |
I/I |
4,166,667 |
9,044,717 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2017-07-11 |
4 |
OE |
$0.05 |
$80,228 |
D/D |
1,706,978 |
277,227,831 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2018-05-03 |
4 |
A |
$1.90 |
$799,400 |
I/I |
420,737 |
722,226 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2018-05-10 |
4 |
OE |
$1.90 |
$500,000 |
I/I |
263,158 |
985,384 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2018-05-10 |
4 |
A |
$1.90 |
$19,397 |
I/I |
10,209 |
995,593 |
0 |
- |
|
DTIL |
Precision Biosciences Inc |
Director |
|
2019-04-01 |
4 |
A |
$0.00 |
$502,466 |
I/I |
93,048 |
93,048 |
0 |
- |
|
COCP |
Cocrystal Pharma |
10% Owner |
|
2019-10-23 |
4 |
B |
$1.04 |
$4,087 |
D/D |
3,935 |
9,244,863 |
2.37 |
- |
|
COCP |
Cocrystal Pharma |
10% Owner |
|
2019-10-24 |
4 |
B |
$1.15 |
$5,858 |
D/D |
5,094 |
9,249,957 |
2.37 |
- |
|
COCP |
Cocrystal Pharma |
10% Owner |
|
2019-10-25 |
4 |
B |
$1.15 |
$9,092 |
D/D |
7,906 |
9,257,863 |
2.37 |
- |
|
COCP |
Cocrystal Pharma |
10% Owner |
|
2021-05-04 |
4 |
S |
$2.95 |
$1,696,250 |
D/D |
(575,000) |
7,674,960 |
0 |
% |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|